What Weedmed does

Weedmed is a Brazilian digital health platform headquartered in Florianópolis that operates a telemedicine service for patients seeking medicinal cannabis treatment. The platform connects individual patients in Brazil with licensed partner physicians who conduct clinical evaluations, issue cannabis-based prescriptions, and monitor ongoing treatment. Weedmed offers both synchronous live teleconsultations and asynchronous case evaluations, the latter involving the sharing of patient clinical data (symptoms, medical history, current medications, anamnesis responses, and documents) with a responsible physician for off-line review.

The underlying technology is a direct-to-consumer web platform (weedmed.com.br) with patient intake forms, secure clinical data handling, and prescription delivery workflows. The platform applies technical controls including encryption in transit and at rest, role-based access, audit logging, and segregation of clinical data, operating in compliance with Brazil's LGPD data protection law, ANVISA regulations (including RDC 660/2022), the Medical Ethics Code, and Receita Federal obligations. No mobile app, API, or SDK is offered.

Weedmed's revenue model is built on consultation fees for clinical services delivered through partner physicians, structured as subscription/recurring revenue per the data classification. Patients register, complete anamnesis, and book consultations directly through the self-serve platform, with logistics and payment operators integrated to support downstream fulfillment. The company is private, founded in 2023, operates with 1–10 employees, and serves only the Brazilian market. No funding rounds, management team, or revenue figures are publicly disclosed.

Name

Weedmed

Legal name

Weedmed

Website

https://weedmed.com.br

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Weedmed is a Brazilian telemedicine platform connecting patients with licensed physicians for medicinal cannabis consultations, prescriptions, and ongoing treatment monitoring, operating in compliance with LGPD and ANVISA regulations.

Ownership category

akta.pro rank

Product category

Telemedicine / Digital Health

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

akta.pro secondary industries

Medical Cannabis Dispensaries (CRANAFAB), Scheduled Cannabis Delivery (Next-Day/Time-Window) (CRANAGAB)

Keywords

• Medicinal cannabis telemedicine
• Cannabis clinical consultations
• Digital health platform
• Medical cannabis prescriptions
• Patient treatment monitoring

Headquarters

HQ city

Florianópolis

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

1. Clinical Consultation Services: The platform facilitates medical consultations between patients and doctors for medicinal cannabis treatment. Revenue is generated through consultation fees for both synchronous (live teleconsultation) and asynchronous (case evaluation without live session) consultation formats. Data sharing with partner physicians occurs for asynchronous evaluations.

Go-to-market motion1 record

Distribution channels1 record

Core offering

Weedmed is a Brazilian digital health platform that connects patients seeking medicinal cannabis treatment with licensed physicians. The platform enables both synchronous live teleconsultations and asynchronous case evaluations, with doctors issuing prescriptions for cannabis-based treatments and monitoring patients throughout their therapy in compliance with ANVISA and LGPD regulations.

Product overview

Weedmed is a healthcare platform focused on monitoring patients in medicinal cannabis treatment. The core offering is the Weedmed Platform, which enables asynchronous medical evaluation (without live teleconsultation), prescription issuance, and personalized treatment content. Patients submit clinical data including symptoms, medical history, and current medications through the platform, which is then reviewed by partner physicians for treatment recommendations.

Differentiator

Problem solved

Functional benefit

Products and services

• Weedmed Platform

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Partner Physicians (Médicos Parceiros)coreOthersWeedmed partners with licensed Brazilian physicians who conduct patient consultations and provide medicinal cannabis prescriptions. For asynchronous evaluations, patient clinical data is shared with the doctor responsible for case analysis. These partnerships are fundamental to service delivery, operating under medical confidentiality obligations.

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• Veriheal: U.S.-based cannabis telehealth and patient-acquisition platform. Comparable on the patient-acquisition and doctor-matching mechanics that drive cannabis telemedicine funnels.
• HempMeds Brasil: Brazilian arm of a global cannabis-hemp company with established ANVISA-authorized product lines. Comparable on the product-distribution side of Weedmed's offering and on Brazilian regulatory navigation.
• Conexa Saúde: Major Brazilian telehealth incumbent serving enterprise and consumer channels. Represents the broader competitive threat if general telehealth players decide to enter cannabis-specific verticals.
• NuggMD: U.S.-focused cannabis telemedicine operator with a large patient and physician network. Provides a scaled-market reference point for subscription-style cannabis consultation monetization.
• Leafwell: International telemedicine platform focused exclusively on medicinal cannabis consultations across multiple U.S. states and selected international markets. Useful comparable for unit economics and operational playbook of pure-play cannabis telehealth.

Direct peers

• Cannabis & Saúde: Brazilian medicinal cannabis platform offering doctor consultations and product access. Directly comparable on geography (Brazil), customer (patients seeking medicinal cannabis), and business model (telehealth + product fulfillment).
• Cannamed: Brazilian medicinal cannabis operator offering physician-mediated treatment and product access. Comparable on patient target, regulatory environment, and combined consultation/product model.
• Dr. Cannabis: Brazil-based medicinal cannabis service connecting patients with prescribing physicians and supplying cannabis-based products. Closest direct competitor given overlapping regulatory positioning under ANVISA.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/weedmed_br

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Weedmed